Evolus, Inc.
NASDAQ Global MarketTotal Valuation
Evolus, Inc. carries a market capitalization of 397.10M, placing it among publicly traded companies globally. Its enterprise value stands at 381.59M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 397.10M |
| Enterprise Value | 381.59M |
Share Statistics
Evolus, Inc. currently has 65.84M shares outstanding.
| Shares Outstanding | 65.84M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.88, and the price-to-book ratio stands at -0.40.
| PE Ratio | N/A |
| PS Ratio | 0.88 |
| PB Ratio | -0.40 |
| P/TBV Ratio | -2.75 |
| P/FCF Ratio | -8.08 |
| P/OCF Ratio | -7.28 |
Enterprise Valuation
| EV / Sales | 1.26 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 1.14 |
Financial Position
Evolus, Inc. maintains a current ratio of 2.04, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -572.96, indicating conservative leverage, while an interest coverage ratio of -1.13 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.04 |
| Quick Ratio | 1.50 |
| Debt / Equity | -572.96 |
| Debt / EBITDA | -7.55 |
| Interest Coverage | -1.13 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -20.01 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -92.65 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.88 |
Taxes
Over the trailing twelve months, Evolus, Inc. has paid 861,000.00 in income taxes, reflecting an effective tax rate of 74.76.
| Income Tax | 861,000.00 |
| Effective Tax Rate | 74.76 |
Stock Price Statistics
Evolus, Inc.'s stock has declined approximately -39.45783% over the past 52 weeks. The 50-day moving average sits at 5.35, while the 200-day moving average is 5.95.
| Beta (5Y) | N/A |
| 52-Week Price Change | -39.45783% |
| 50-Day Moving Average | 5.35 |
| 200-Day Moving Average | 5.95 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Evolus, Inc. generated 301.79M in revenue and converted that into -43.42M in net income, yielding earnings per share of -0.67. EBITDA reached -21.83M, while operating income came in at -31.44M.
| Revenue | 301.79M |
| Gross Profit | 199.35M |
| Operating Income | -31.44M |
| Pretax Income | -42.56M |
| Net Income | -43.42M |
| EBITDA | -21.83M |
| EBIT | -31.44M |
| Earnings Per Share (EPS) | -0.67 |
Balance Sheet
Evolus, Inc. holds 49.79M in cash and equivalents against 164.90M in total debt, resulting in a net debt position of 106.62M. Total book value stands at -671.71M, with working capital of 70.90M providing operational flexibility.
| Cash & Cash Equivalents | 49.79M |
| Total Debt | 164.90M |
| Net Debt | 106.62M |
| Equity (Book Value) | -671.71M |
| Book Value Per Share | -10.36 |
| Working Capital | 70.90M |
Cash Flow
Evolus, Inc. produced -36.58M in operating cash flow over the past twelve months. After subtracting -3.54M in capital expenditures, free cash flow totaled -40.12M - equivalent to -0.62 per share.
| Operating Cash Flow | -36.58M |
| Capital Expenditures | -3.54M |
| Free Cash Flow | -40.12M |
| FCF Per Share | -0.62 |
Margins
Evolus, Inc. operates with a gross margin of 66.06, reflecting its pricing power and cost economics. The operating margin of -10.42 and net profit margin of -14.39 provide insight into operational efficiency.
| Gross Margin | 66.06 |
| Operating Margin | -10.42 |
| Pretax Margin | -14.10 |
| Profit Margin | -14.39 |
| EBITDA Margin | -7.23 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -9.98 |
| FCF Yield | -12.38 |
Scores
Evolus, Inc. posts an Altman Z-Score of -3.66, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -3.66 |